{"id":"W3035438457","doi":"10.15586/jptcp.v27i2.673","title":"Regulatory approval and public drug plan listing of new drugs for rare disorders in Canada and New Zealand","year":2020,"lang":"en","type":"article","venue":"Journal of Population Therapeutics and Clinical Pharmacology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Fraser Institute; Canadian Institute for Health Information","funders":"","keywords":"Formulary; Orphan drug; Listing (finance); Negotiation; Business; Reimbursement; Public health; Population; Pharmaceutical industry; Medicine; Family medicine; Health care; Finance; Environmental health; Political science; Economic growth; Pharmacology; Economics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005785845,0.0001761894,0.0004483404,0.003326841,0.002092092,0.004032388,0.0008968847,0.0007725143,0.00677504],"category_scores_gemma":[0.02890858,0.0003875179,0.0008213659,0.00390149,0.001367192,0.001102498,0.000967714,0.001784183,0.0002500475],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0629814,"about_ca_system_score_gemma":0.1152547,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9806739,"about_ca_topic_score_gemma":0.9806646,"domain_scores_codex":[0.9866048,0.001068737,0.0006132516,0.0007499142,0.007687598,0.003275775],"domain_scores_gemma":[0.9687153,0.00646152,0.00787268,0.0007849245,0.01261896,0.003546656],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001355031,0.0003297314,0.6238682,0.0009459093,0.0006473991,0.001471317,0.004368552,0.009761815,0.002054323,0.1023385,0.1039603,0.148899],"study_design_scores_gemma":[0.0001808757,0.000111471,0.8862923,0.0002588085,0.000146047,0.0002459979,0.002377472,0.004475182,0.0007162424,0.00166507,0.1034164,0.0001142094],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6987112,0.005575198,0.002810377,0.03246933,0.0002508394,0.0009916009,0.01826787,0.0002100114,0.2407135],"genre_scores_gemma":[0.9746332,0.001634607,0.001856604,0.003430513,0.00006474178,0.0001226932,0.005093387,0.00003907236,0.01312536],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9370186,"threshold_uncertainty_score":0.4569641,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1378897145925976,"score_gpt":0.3535029254053446,"score_spread":0.2156132108127469,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}